Platinum-based chemotherapy - Globe Thesis

Keyword [Platinum-based chemotherapy] Result: 1 - 20 \| Page: 1 of 4
1.	Single Nucleotide Polymorphisms And Therapy Response To Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
2.	Study On The Association Between CASP Family Gene Mutation And Platinum - Containing Chemotherapy In Advanced Non - Small Cell Lung Cancer
3.	Apoptosis - Related Gene Single Nucleotide Polymorphism And Platinum Therapy For Advanced Non - Small Cell Lung Cancer
4.	Meta Analysis Of P53 Expression On Response To Platinum-based Chemotherapy In NSCLC Patients And Experimental Study Of RAd-p53 Enhance Sensitivity Of NSCLC Cells To Cisplatin
5.	Association Between ERCC6-6530 Single Nucleotide Polymorphism And Prognosis Of Small Cell Lung Cancer Patients Treated With Platinum-based Chemotherapy
6.	Functional ERCC1 And XPF Variants Are Associated With Susceptibility To Lung Cancer But Resistance To Platinum-Based Chemotherapy
7.	Detection And Functional Analysis Of SNPs In The ERCC5 Promoter In Patients With Advanced Colorectal Cancer Treated With Platinum-based Chemotherapy
8.	The Study Of Predictive Markers For Platinum-based Chemotherapy In Gastric Cancer And The Regulation Of 'Chong Lou Fu Fang' On The Expression Of Chemotherapeutic Agents Associated Genes
9.	Predictive Role Of TGFBR2 Gene Ploymorphysoms On Advanced NSCLC Treated With Platinum-based
10.	Dna Damage Repair Genetic Polymorphisms And Lung Cancer Susceptibility And Pharmacogenomics Research
11.	Correlation Of Gene Polymorphisms And The Prognosis, Response To Treatment Of Patients With Triple Negative Breast Cancer
12.	The Analysis Of Expression Of ERCC1, XPD Proteins And Quantitative Nuclear Grade On Prediction Of The Response To Platinum-based Chemotherapy In Advanced Epithelial Ovarian Cancers
13.	The Study On The Expression Of ERCC1,HMGB1,Bcl-2/Bax,Caspase-3 And The Correlation With Platinum-based Chemotherapy Sensitivity And Prognosis In Ⅲa Stage Non-small Cell Lung Carcinoma
14.	Study On The Relationship Between The Expression Of ERCC1 And Platinum-Based Chemotherapy Resistance In Advanced Non-Small Cell Lung Cancer
15.	Expression Of ERCC1 And The Correlation With Platinum-based Chemotherapy Sensitivity And Clinical Significance In The Advanced Non-small Cell Lung Cancer
16.	Retrospective Research Of Endostar Combined With Platinum-based Chemotherapy For Advanced Non-small Cell Lung Cancer
17.	Study On The Relationship Between The Genetic Polymorphisms Of EIF3a And Susceptibility Of Lung Cancer Development And Clinical Sensitivity To Platinum-based Chemotherapy In Patients With Lung Cancer
18.	Expression Of ERCC1 Predicts The Survival And Correlates With The Response Rate Treated With Platinum-based Chemotherapy In Esophageal Squamous Cell Cancer
19.	Multivariate Analysis Of Early Response To Platinum-based Chemotherapy In Advanced Non-small-cell Lung Cancer
20.	Association Between Hsa-miR-196a2 Functional Polymorphism And Prognosis After Platinum-Based Chemotherapy Of Advanced Non-Small Cell Lung Cancer Patients In A Chinese Population
<<First <Prev Next> Last>> Jump to